Navigation Links
A*STAR scientist wins European Molecular Biology Organization Young Investigator award
Date:11/7/2013

1. Dr Florent Ginhoux, Principal Investigator at the Singapore Immunology Network (SIgN), has been awarded the prestigious EMBO Young Investigator 2013 award. The European Molecular Biology Organization (EMBO) Young Investigator Programme (YIP) recognises young, promising researchers who are less than forty years of age and who have established their first laboratories in Europe and EMBO cooperation partner countries in the past four years.

2. Dr Ginhoux is one of only three scientists outside of Europe to receive the EMBO YIP award since its launch in year 2000. Of these three awardees, two are from Singapore and Dr Ginhoux is the second scientist in Singapore to be awarded . His excellence in the research won him the Best Paper Award at the 10th International Symposium on Dendritic Cells held in 2008. He also published several already well-cited papers in the prestigious Science and Immunity journals since he started his laboratory at SIgN in 2009. He was awarded the EMBO YIP as EMBO saw his accomplishments and potential to become a future life sciences leader.

3. Dr Ginhoux's current research focuses on understanding the origin and functions of dendritic cells (DCs), a specialised group of white blood cells which are responsible for triggering immune responses. His research forms the basis of a conceptual framework that can be translated into useful clinical applications since all immune responses against infectious agents are activated and regulated by DCs. Dr Ginhoux's study on DCs is highly significant in the design of clinical therapies, such as vaccines and immunotherapies for infections or auto-immune diseases.

4. Dr Ginhoux said, "This achievement would not have been possible without my dedicated team and the excellent scientific environment found in SIgN, as well as the research facilities in A*STAR. I'm truly honoured to be selected for the EMBO Young Investigator Programme and I would like to thank both A*STAR and my team for their support."

5. Prof Sir David Lane, A*STAR Chief Scientist and EMBO member said, "Only twelve per cent of the applicants were selected for the programme this year and we are pleased that Florent is one of them. Florent is a promising young scientist with great potential to be a scientific leader of the next generation. His passion in immunology has brought about important discoveries with potential clinical applications. We hope that this recognition will spur him on to make greater discoveries in his research."

6. Mr Lim Chuan Poh, A*STAR Chairman, said, "Florent is a fine example of the world class international talent that we are attracting to pursue their research careers in Singapore. A*STAR is very happy and proud that Florent's excellent work has been recognised by EMBO. A*STAR believes that his success will not only serve to inspire the younger scientists around him to similarly strive for excellence, but will also draw other promising international scientists to pursue their research careers in Singapore and with A*STAR. This is part of A*STAR's talent strategy of nurturing a strong Singaporean core to be complemented by a rich diversity of international scientists."

7. Dr Ginhoux will receive a financial award of 15,000 euros per year for his three years of membership. He will also receive extensive support from EMBO for networking opportunities. More details on the other 2013 EMBO YIP awardees, EMBO YIP and EMBO can be found in Annex A.


'/>"/>

Contact: Tan Yun Yun
tan_yun_yun@a-star.edu.sg
65-682-66273
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Related medicine news :

1. A*STAR scientists discover switch to boost anti-viral response to fight infectious diseases
2. Fruit flies light the way for A*STAR scientists to pinpoint genetic changes that spell cancer
3. A*STAR scientists identify potential drug target for inflammatory diseases including cancers
4. Singapore scientists led by A*STARs GIS identify 4 mechanisms that contribute to gastric cancers
5. A*STAR scientists discover switch critical to wound healing
6. A*STAR scientist Alex Matter awarded prestigious Szent-Györgyi Prize for progress in cancer
7. Scientists solving the mystery of human consciousness
8. Scientists uncover multiple faces of deadly breast cancer
9. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
10. Scientists identify major source of cells defense against oxidative stress
11. Scientists tailor cell surface targeting system to hit organelle ZIP codes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Brady ... announced that its B-595 and B-7569 vinyl label materials received ... and warning labels are tested to remain intact and legible, for use on chemical ...
(Date:4/21/2017)... Colo. (PRWEB) , ... April 21, 2017 , ... The ... the Flex House, the next project in the company’s esteemed VISION House demonstration project ... homeowners use exactly the amount of resources they need to live affordably and abundantly ...
(Date:4/21/2017)... ... ... The Hong Kong Polytechnic University (PolyU) launched today the University Research Facility in ... Kong to support teaching, learning and research. It is also the largest research centre ... Kong. , With an area of 620 square metres and more than 50 ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Alive ... people who wish to overcome their mental health struggles. The Alive team uses ... LeBouthillier says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens ... of International Trade, the UK’s most prestigious award for business success. The ... of total revenues and has grown by a total of 400% over the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)... April 19, 2017  New research provides evidence that an ... according to a study released today that will be presented ... in Boston , April 22 to ... treatment of Parkinson,s disease, the oral drug levodopa has long ... longevity. But as the disease progresses, the effects of the ...
Breaking Medicine Technology: